Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 649.75 Thousand USD | 0.0% |
| 2023 | 939.64 Thousand USD | 55.96% |
| 2022 | 602.5 Thousand USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 42.54 Thousand USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 841.15 Thousand USD | 62.01% |
| 2017 | 519.2 Thousand USD | -1.63% |
| 2016 | 527.78 Thousand USD | 240.0% |
| 2015 | 155.22 Thousand USD | -80.01% |
| 2014 | 776.45 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 395 Thousand USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 798.45 Thousand USD | 0.0% |
| 2024 Q4 | 649.75 Thousand USD | 0.0% |
| 2024 Q3 | 724.84 Thousand USD | 0.0% |
| 2024 FY | 649.75 Thousand USD | -30.85% |
| 2024 Q1 | 869.94 Thousand USD | 0.0% |
| 2023 Q2 | 1.07 Million USD | 89.93% |
| 2023 Q3 | 1 Million USD | -6.33% |
| 2023 FY | 939.64 Thousand USD | 55.96% |
| 2023 Q1 | 567.32 Thousand USD | -5.84% |
| 2023 Q4 | 939.64 Thousand USD | -6.9% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 602.5 Thousand USD | 0.0% |
| 2022 Q4 | 602.5 Thousand USD | 109.77% |
| 2022 Q3 | 287.22 Thousand USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 16.83 Thousand USD | -60.43% |
| 2020 Q3 | 67.69 Thousand USD | -26.9% |
| 2020 Q4 | 42.54 Thousand USD | -37.16% |
| 2020 FY | 42.54 Thousand USD | 0.0% |
| 2020 Q1 | 117.25 Thousand USD | 0.0% |
| 2020 Q2 | 92.6 Thousand USD | -21.03% |
| 2019 FY | - USD | -100.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q1 | 871.44 Thousand USD | 3.6% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 Q2 | 780.57 Thousand USD | -25.72% |
| 2018 Q4 | 841.15 Thousand USD | 3.74% |
| 2018 FY | 841.15 Thousand USD | 62.01% |
| 2018 Q1 | 1.05 Million USD | 102.41% |
| 2018 Q3 | 810.86 Thousand USD | 3.88% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q4 | 519.2 Thousand USD | 25.29% |
| 2017 FY | 519.2 Thousand USD | -1.63% |
| 2017 Q1 | 616.81 Thousand USD | 16.87% |
| 2017 Q3 | 414.39 Thousand USD | 0.0% |
| 2016 Q4 | 527.78 Thousand USD | 0.0% |
| 2016 FY | 527.78 Thousand USD | 240.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q3 | 264.25 Thousand USD | -73.32% |
| 2015 Q1 | 1 Million USD | 28.98% |
| 2015 FY | 155.22 Thousand USD | -80.01% |
| 2015 Q4 | 155.22 Thousand USD | -41.26% |
| 2015 Q2 | 990.52 Thousand USD | -1.09% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 776.45 Thousand USD | 0.0% |
| 2014 FY | 776.45 Thousand USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 Q3 | 375 Thousand USD | -5.06% |
| 2002 Q1 | 395 Thousand USD | 0.0% |
| 2002 Q2 | 395 Thousand USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q4 | - USD | -100.0% |
| 2001 FY | 395 Thousand USD | 0.0% |
| 2001 Q3 | 223.13 Thousand USD | 0.0% |
| 2001 Q4 | 395 Thousand USD | 77.02% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 98.2% |
| BrainsWay Ltd. | 239 Thousand USD | -171.862% |
| Cerus Corporation | 59.79 Million USD | 98.913% |
| Envoy Medical, Inc. | 404 Thousand USD | -60.829% |
| electroCore, Inc. | 537 Thousand USD | -20.996% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -5314.592% |
| IceCure Medical Ltd | 376 Thousand USD | -72.806% |
| Inogen, Inc. | 18.27 Million USD | 96.444% |
| OrthoPediatrics Corp. | 13.45 Million USD | 95.172% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -226.508% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -78.638% |
| MaxCyte, Inc. | 17.96 Million USD | 96.384% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -1075.297% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.302% |
| PAVmed Inc | 2.96 Million USD | 78.049% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 89.544% |
| RxSight, Inc. | 1.21 Million USD | 46.346% |
| Sight Sciences, Inc. | 31.7 Million USD | 97.951% |
| SI-BONE, Inc. | 36.06 Million USD | 98.198% |
| TELA Bio, Inc. | 40.51 Million USD | 98.396% |
| Treace Medical Concepts, Inc. | 53 Million USD | 98.774% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 57.281% |
| Acutus Medical, Inc. | 32.65 Million USD | 98.01% |
| Talis Biomedical Corporation | 16.78 Million USD | 96.129% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 83.937% |
| CVRx, Inc. | 30.38 Million USD | 97.861% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 36.107% |
| Bioventus Inc. | 366.99 Million USD | 99.823% |
| Venus Concept Inc. | 70.79 Million USD | 99.082% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 47.769% |
| LivaNova PLC | 568.54 Million USD | 99.886% |
| 908 Devices Inc. | 3.92 Million USD | 83.463% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.873% |
| Nemaura Medical Inc. | 3.08 Million USD | 78.956% |
| NeuroPace, Inc. | 56.95 Million USD | 98.859% |
| LENSAR, Inc. | 1.75 Million USD | 62.871% |
| Apyx Medical Corporation | 33.18 Million USD | 98.042% |
| Cutera, Inc. | 418.69 Million USD | 99.845% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 95.681% |
| BioSig Technologies, Inc. | 103 Thousand USD | -530.826% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 97.585% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 93.469% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.956% |
| Axonics, Inc. | 25.84 Million USD | 97.485% |
| Outset Medical, Inc. | 134.59 Million USD | 99.517% |
| IRIDEX Corporation | 1.75 Million USD | 62.893% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 98.734% |
| IRadimed Corporation | 1.61 Million USD | 59.77% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -269.177% |
| INVO Bioscience, Inc. | 6.77 Million USD | 90.411% |
| Telesis Bio, Inc. | 5.26 Million USD | 87.668% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 89.119% |
| Varex Imaging Corporation | 464.2 Million USD | 99.86% |
| Quipt Home Medical Corp. | 60.82 Million USD | 98.932% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10.502% |
| Pulmonx Corporation | 35.08 Million USD | 98.148% |
| Dynatronics Corporation | 3.25 Million USD | 80.06% |
| Modular Medical, Inc. | 817 Thousand USD | 20.471% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -330.299% |
| Semler Scientific, Inc. | 70 Thousand USD | -828.216% |
| InMode Ltd. | 6.61 Million USD | 90.175% |
| Bruker Corporation | 1.14 Billion USD | 99.943% |
| Cytosorbents Corporation | 2.54 Million USD | 74.448% |
| DexCom, Inc. | 2.57 Billion USD | 99.975% |
| Align Technology, Inc. | 96.96 Million USD | 99.33% |
| Viveve Medical, Inc. | 5.12 Million USD | 87.319% |
| ZimVie Inc. | 508.79 Million USD | 99.872% |
| Movano Inc. | 15.00 USD | -4331573.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 96.415% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.837% |
| Profound Medical Corp. | 4.97 Million USD | 86.938% |
| Insulet Corporation | 1.36 Billion USD | 99.952% |
| enVVeno Medical Corporation | 1.06 Million USD | 38.933% |
| Surmodics, Inc. | 29.4 Million USD | 97.79% |
| iCAD, Inc. | 273 Thousand USD | -138.004% |
| Nuwellis, Inc. | 221 Thousand USD | -194.005% |
| Biotricity, Inc. | 10.85 Million USD | 94.015% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 98.141% |
| InspireMD, Inc. | 1.03 Million USD | 37.404% |
| PAVmed Inc. | 2.96 Million USD | 78.049% |
| BIOLASE, Inc. | 13.98 Million USD | 95.354% |
| Beyond Air, Inc. | 14.72 Million USD | 95.586% |
| FONAR Corporation | 37.92 Million USD | 98.287% |
| AxoGen, Inc. | 46.6 Million USD | 98.606% |
| Vivani Medical, Inc. | 19.31 Million USD | 96.636% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 98.544% |
| Inari Medical, Inc. | 30.35 Million USD | 97.859% |
| UFP Technologies, Inc. | 28 Million USD | 97.679% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -49.697% |
| Tenon Medical, Inc. | 428 Thousand USD | -51.811% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 35.155% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 69.81% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.969% |
| Sintx Technologies, Inc. | 3.68 Million USD | 82.377% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 98.254% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -10.502% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -9.019% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.927% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.872% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -7.043% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -602.547% |
| Hyperfine, Inc. | 64 Thousand USD | -915.236% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.656% |
| Biomerica, Inc. | 459 Thousand USD | -41.558% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -44.555% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -241.998% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.141% |